Parapneumonic empyema deaths during past century, Utah

Emerging Infectious Diseases

Volumn 15, Issue 1, 2009, Pages 44-48

  Bender, Jeffrey M ^a   Ampofo, Krow ^a   Sheng, Xiaoming ^a   Pavia, Andrew T ^a   Cannon Albright, Lisa ^a   Byington, Carrie L ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; CHILD; DEATH; EMPYEMA; HUMAN; INFANT; INFLUENZA; MAJOR CLINICAL STUDY; MORTALITY; PANDEMIC; PARAPNEUMONIC EMPYEMA; PRESCHOOL CHILD; REVIEW; SCHOOL CHILD; UNITED STATES;

ADOLESCENT; ADULT; CHILD; DISEASE OUTBREAKS; EMPYEMA, PLEURAL; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; INFANT; INFLUENZA, HUMAN; PNEUMONIA, BACTERIAL; PNEUMONIA, PNEUMOCOCCAL; UTAH;

EID: 58849132438     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid1501.080618     Document Type: Review

References (40)

1. Klugman KP, Madhi SA. Pneumococcal vaccines and flu preparedness. Science. 2007;316:49c-50. DOI: 10.1126/science.316.5821.49c
2. Pandemic influenza: the state of the science. Trust for America's Health: Infectious Disease Society of America; 2006 [cited 2008 Nov 19]. Available from http://healthyamericans.org/reports/fluscience
3. Whitley RJ, Bartlett J, Hayden FG, Pavia AT, Tapper M, Monto AS. Seasonal and pandemic influenza: recommendations for preparedness in the United States. J Infect Dis. 2006;194 (Suppl 2):S155-61.
4. Morens DM, Taubenberger JK, Fauci AS. Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: implications for pandemic influenza preparedness. J Infect Dis. 2008;198:962-70. DOI: 10.1086/591708
5. Morens DM, Fauci AS. The 1918 influenza pandemic: insights for the 21st century. J Infect Dis. 2007;195:1018-28. DOI: 10.1086/511989
6. Taubenberger JK, Morens DM. 1918 Influenza: the mother of all pandemics. Emerg Infect Dis. 2006;12:15-22.
7. Brundage JF, Shanks GD. Deaths from bacterial pneumonia during 1918-19 influenza pandemic. Emerg Infect Dis. 2008;14:1193-9. DOI: 10.3201/eid1408. 071313
8. Gupta RK, George R, Nguyen-Van-Tam JS. Bacterial pneumonia and pandemic influenza planning. Emerg Infect Dis. 2008;14:1187-92. DOI: 10.3201/eid1407. 070751
9. Heron MP, Smith BL. Deaths: leading causes for 2003. Natl Vital Stat Rep. 2007;10:1-92.
10. Armstrong GL, Conn LA, Pinner RW. Trends in infectious disease mortality in the United States during the 20th century. JAMA. 1999;281:61-6. DOI: 10.1001/jama.281.1.61
11. Singleton RJ, Hennessy TW, Bulkow LR, Hammitt LL, Zulz T, Hurlburt DA, et al. Invasive pneumococcal disease caused by nonvaccine serotypes among Alaska native children with high levels of 7-valent pneumococcal conjugate vaccine coverage. JAMA. 2007;297:1784-92. DOI: 10.1001/jama.297.16.1784
12. Rees JHSD, Parikh D, Weller P. Increase in incidence of childhood empyema in West Midlands, UK. Lancet. 1997;349:402. DOI: 10.1016/S0140-6736(97)80022-0
13. Lin CJ, Chen PY, Huang FL, Lee T, Chi CS, Lin CY. Radiographic, clinical, and prognostic features of complicated and uncomplicated community-acquired lobar pneumonia in children. J Microbiol Immunol Infect. 2006;39:489-95.
14. Eastham KMFR, Kearns AM, Eltringham G, Clark J, Leeming J, Spencer DA. Clinical features, aetiology and outcome of empyema in children in the north east of England. Thorax. 2004;59:522-5. DOI: 10.1136/thx.2003.016105
15. Byington CLKK, Daly J, Ampofo K, Pavia A, Mason EO. Impact of the pneumococcal conjugate vaccine on pneumococcal parapneumonic empyema. Pediatr Infect Dis J. 2006;25:250-4. DOI: 10.1097/01.inf.0000202137.37642.ab
16. Messina AF, Katz-Gaynor K, Barton T, Ahmad N, Ghaffar F, Rasko D, et al. Impact of the pneumococcal conjugate vaccine on serotype distribution and antimicrobial resistance of invasive Streptococcus pneumoniae isolates in Dallas, TX, children from 1999 through 2005. Pediatr Infect Dis J. 2007;26:461-7. DOI: 10.1097/INF.0b013e31805cdbeb
17. Pelton SI, Huot H, Finkelstein JA, Bishop CJ, Hsu KK, Kellenberg J, et al. Emergence of 19A as virulent and multidrug resistant Pneumococcus in Massachusetts following universal immunization of infants with pneumococcal conjugate vaccine. Pediatr Infect Dis J. 2007;26:468-72. DOI: 10.1097/INF.0b013e31803df9ca
18. Centers for Disease Control and Prevention. Severe methicillin-resistant Staphylococcus aureus community-acquired pneumonia associated with influenza - Louisiana and Georgia, December 2006-January 2007. MMWR Morb Mortal Wkly Rep. 2007;56:325-9.
19. Francis JS, Doherty MC, Lopatin U, Johnston CP, Sinha G, Ross T, et al. Severe community-onset pneumonia in healthy adults caused by methicillin-resistant Staphylococcus aureus carrying the Panton-Valentine leukocidin genes. Clin Infect Dis. 2005;40:100-7. DOI: 10.1086/427148
20. Li S-TT. Empyema hospitalizations increasing in the U.S. despite decreasing invasive pneumococcal disease post-introduction of the pneumococcal conjugate vaccine. Pediatric Academic Society Meeting (4055.4); Honolulu (HI); 2008 May 2-6.
21. Byington CLSM, Stoddard GJ, Barlow S, Daly J, Korgenski K, Firth S, et al. Temporal trends of invasive disease due to Streptococcus pneumoniae among children in the intermountain west: emergence of nonvaccine serogroups. Clin Infect Dis. 2005;41:21-9. DOI: 10.1086/430604
22. Osler W, McCrae T. The principles and practice of medicine. 8th ed. New York: D. Appleton and Company; 1914.
23. Johnson NP, Mueller J. Updating the accounts: global mortality of the 1918-1920 "Spanish" influenza pandemic. Bull Hist Med. 2002;76:105-15. DOI: 10.1353/bhm.2002.0022
24. Moore M, Whitney C. Bacterial pneumonia associated with pandemic influenza. 2007 Infectious Diseases Society of America Annual Meeting; San Diego (CA); 2007 Oct 4-7.
25. McCullers JA. Insights into the interaction between influenza virus and pneumococcus. Clin Microbiol Rev. 2006;19:571-82. DOI: 10.1128/CMR.00058-05
26. McCullers JA, Rehg JE. Lethal synergism between influenza virus and Streptococcus pneumoniae: characterization of a mouse model and the role of platelet-activating factor receptor. J Infect Dis. 2002;186:341-50. DOI: 10.1086/341462
27. Speshock JL, Doyon-Reale N, Rabah R, Neely MN, Roberts PC. Filamentous influenza A virus infection predisposes mice to fatal septicemia following superinfection with Streptococcus pneumoniae serotype 3. Infect Immun. 2007;75:3102-11. DOI: 10.1128/IAI.01943-06
28. Ampofo K, Bender J, Sheng X, Korgenski K, Daly J, Pavia AT, et al. Seasonal invasive pneumococcal disease in children: role of preceding respiratory viral infection. Pediatrics. 2008;122:229-37. DOI: 10.1542/peds.2007-3192
29. Gonzalez BE, Hulten KG, Dishop MK, Lamberth LB, Hammerman WA, Mason EO Jr, et al. Pulmonary manifestations in children with invasive community-acquired Staphylococcus aureus infection. Clin Infect Dis. 2005;41:583-90. DOI: 10.1086/432475
30. Obando I, Arroyo LA, Sanchez-Tatay D, Moreno D, Hausdorff WP, Brueggemann AB. Molecular typing of pneumococci causing parapneumonic empyema in Spanish children using multilocus sequence typing directly on pleural fluid samples. Pediatr Infect Dis J. 2006;25:962-3. DOI: 10.1097/01.inf.0000235684.89728.38
31. Langley J, Kellner J, Robinson J. Vaccine-preventable empyema due to community-acquired pneumonia in Canadian children: A PICNIC study. 7th Canadian Immunization Conference. Winnipeg, Manitoba, Canada; 2006 Dec 3-6.
32. Centers for Disease Control and Prevention. Invasive pneumococcal disease in children 5 years after conjugate vaccine introduction - eight states, 1998-2005. MMWR Morb Mortal Wkly Rep. 2008;57:144-8.
33. Kyaw MH, Lynfield R, Schaffner W, Craig AS, Hadler J, Reingold A, et al. Effect of introduction of the pneumococcal conjugate vaccine on drug-resistant Streptococcus pneumoniae. N Engl J Med. 2006;354:1455-63. DOI: 10.1056/NEJMoa051642
34. Talbot TR, Poehling KA, Hartert TV, Arbogast PG, Halasa NB, Mitchel E, et al. Reduction in high rates of antibiotic-nonsusceptible invasive pneumococcal disease in Tennessee after introduction of the pneumococcal conjugate vaccine. Clin Infect Dis. 2004;39:641-8. DOI: 10.1086/422653
35. Lexau CA, Lynfield R, Danila R, Pilishvili T, Facklam R, Farley MM, et al. Changing epidemiology of invasive pneumococcal disease among older adults in the era of pediatric pneumococcal conjugate vaccine. JAMA. 2005;294:2043-51. DOI: 10.1001/jama.294.16.2043
36. Bender JM, Ampofo K, Korgenski K, Daly J, Pavia AT, Mason EO Jr, et al. Pneumococcal necrotizing pneumonia in Utah: does serotype matter? Clin Infect Dis. 2008.
37. Gillet Y, Vanhems P, Lina G, Bes M, Vandenesch F, Floret D, et al. Factors predicting mortality in necrotizing community-acquired pneumonia caused by Staphylococcus aureus containing Panton-Valentine leukocidin. Clin Infect Dis. 2007;45:315-21. DOI: 10.1086/519263
38. Moran GJ, Krishnadasan A, Gorwitz RJ, Fosheim GE, McDougal LK, Carey RB, et al. Methicillin-resistant S. aureus infections among patients in the emergency department. N Engl J Med. 2006;355:666-74. DOI: 10.1056/NEJMoa055356
39. US Department of Health and Human Services. Pandemic influenza plan. Washington: The Department; 2005.
40. Pandemic and seasonal influenza: principles for US action; Infectious Diseases Society of America, 2007 [cited 2008 Nov 19]. Available from http://www.idsociety.org/Content.aspx?id=5712